JP2006193428A5 - - Google Patents

Download PDF

Info

Publication number
JP2006193428A5
JP2006193428A5 JP2005003654A JP2005003654A JP2006193428A5 JP 2006193428 A5 JP2006193428 A5 JP 2006193428A5 JP 2005003654 A JP2005003654 A JP 2005003654A JP 2005003654 A JP2005003654 A JP 2005003654A JP 2006193428 A5 JP2006193428 A5 JP 2006193428A5
Authority
JP
Japan
Prior art keywords
ferrous
iron
rutin
pyrophosphate
citrate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2005003654A
Other languages
Japanese (ja)
Other versions
JP2006193428A (en
JP4722492B2 (en
Filing date
Publication date
Application filed filed Critical
Priority to JP2005003654A priority Critical patent/JP4722492B2/en
Priority claimed from JP2005003654A external-priority patent/JP4722492B2/en
Publication of JP2006193428A publication Critical patent/JP2006193428A/en
Publication of JP2006193428A5 publication Critical patent/JP2006193428A5/ja
Application granted granted Critical
Publication of JP4722492B2 publication Critical patent/JP4722492B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Description

本発明に係る鉄化合物としては、クエン酸鉄、クエン酸第１鉄ナトリウム、グルコン酸第１鉄、乳酸鉄、フマル酸第１鉄、ピロリン酸第１鉄、ピロリン酸第２鉄、及び硫酸第１鉄が好ましい。鉄化合物は市販品を用いればよく、１種又は２種以上を適宜選択して使用することができる。   Examples of the iron compound according to the present invention include iron citrate, sodium ferrous citrate, ferrous gluconate, iron lactate, ferrous fumarate, ferrous pyrophosphate, ferric pyrophosphate, and sulfuric acid ferrous acid. One iron is preferred. A commercially available iron compound may be used, and one or two or more may be appropriately selected and used.

Claims (1)

ルチン及び／又はルチン誘導体、クエン酸鉄、クエン酸第１鉄ナトリウム、グルコン酸第１鉄、乳酸鉄、フマル酸第１鉄、ピロリン酸第１鉄、ピロリン酸第２鉄、及び硫酸第１鉄からなる群より選択される一種又は二種以上の鉄化合物、及びエゾウコギの抽出物を含有することを特徴とする鉄欠乏性貧血に伴う不定愁訴の予防又は改善剤。 Rutin and / or rutin derivatives, iron citrate, ferrous sodium citrate, ferrous gluconate, ferrous lactate, ferrous fumarate, ferrous pyrophosphate, ferric pyrophosphate, and ferrous sulfate A prophylactic or ameliorating agent for indefinite complaints associated with iron deficiency anemia, comprising one or two or more iron compounds selected from the group consisting of:
JP2005003654A 2005-01-11 2005-01-11 An agent for preventing or ameliorating indefinite complaints associated with iron deficiency anemia. Active JP4722492B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2005003654A JP4722492B2 (en) 2005-01-11 2005-01-11 An agent for preventing or ameliorating indefinite complaints associated with iron deficiency anemia.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2005003654A JP4722492B2 (en) 2005-01-11 2005-01-11 An agent for preventing or ameliorating indefinite complaints associated with iron deficiency anemia.

Publications (3)

Publication Number Publication Date
JP2006193428A JP2006193428A (en) 2006-07-27
JP2006193428A5 true JP2006193428A5 (en) 2007-02-15
JP4722492B2 JP4722492B2 (en) 2011-07-13

Family

ID=36799783

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2005003654A Active JP4722492B2 (en) 2005-01-11 2005-01-11 An agent for preventing or ameliorating indefinite complaints associated with iron deficiency anemia.

Country Status (1)

Country Link
JP (1) JP4722492B2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5270893B2 (en) * 2007-10-01 2013-08-21 サントリーホールディングス株式会社 Process for producing rapidly disintegrating granules containing off-flavor ingredients
CN108042595B (en) * 2018-01-23 2021-01-15 康美（北京）药物研究院有限公司 Composition with health care function and preparation method and application thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05246842A (en) * 1992-03-06 1993-09-24 Ruibosuteii Japan:Kk Agent for ameliorating and curing anemia
JP2000226327A (en) * 1999-02-04 2000-08-15 Taisho Pharmaceut Co Ltd Oral liquid formulation
JP2003038140A (en) * 2001-07-31 2003-02-12 I-Deal Coms Kk Nutritional beverage containing acanthopanax senticosus harms

Similar Documents

Publication Publication Date Title
JP2012107014A5 (en)
JP2006257553A5 (en)
JP2003506345A5 (en)
WO2007058602A3 (en) Novel 2-amino-imidazole-4-one compounds and their use in the manufacture of a medicament to be used in the treatment of cognitive impairment, alzheimer’s disease, neurodegeneration and dementia.
RS52214B (en) Pharmaceutical formaulations of hdac inibitors
JP2011088897A5 (en)
RU2007122365A (en) ZIN CONTAINING ORAL COMPOSITION WITH IMPROVED TASTE
WO2004074444A3 (en) Ferric organic compounds, uses thereof and methods of making same
MY144999A (en) Method of preparing microfibrillar polysaccharide
JP2008511536A5 (en)
UY29857A1 (en) DERIVATIVES OF 4-AMINO-QUINAZOLINA, ITS PREPARATION AND ITS APPLICATION IN THERAPEUTICS.
JP2008513510A5 (en)
JP2006515358A5 (en)
JP2008285480A5 (en)
WO2007136727A3 (en) Iron (ii) amino acid chelates with reducing agents attached thereto
JP2008501844A5 (en)
JP2006193428A5 (en)
JP2009538982A5 (en)
JP2009242695A5 (en)
JP2004520264A5 (en)
UY29744A1 (en) DERIVATIVES OF 5-PIRIDINIL-1-AZABICICLO (3.2.1) OCTANO, ITS PREPARATION AND ITS APPLICATION IN THERAPEUTICS.
ATE367434T1 (en) ACID SOLIDS
DE602006012779D1 (en) Antioxidant composition having excellent antiblocking property
DE60203890D1 (en) ACETIC ACID ADDITIONAL SALT OF TERBINAFIN
JP2009019225A5 (en)